The President’s actions (or distractions) may be detrimental to Western medical device companies.
With the increase of diabetes prevalence in Asia and the rise of Asia’s middle classes, the demand for newer and better treatments will provide opportunities for Western medtech companies.
As standalone software becomes increasingly sophisticated, a number of regulatory bodies have begun to draft separate guidelines to ensure quality control, expedite product approval, and improve patient access to new technologies.
Global sports medicine is predicted to grow to around $35 billion by 2022, with the Asian market growing at a compound annual growth rate of nearly 7 percent.
Increased prevalence and awareness of neurological disorders in Asia present market growth opportunities for neurology companies.
As Asians get wealthier and more concerned about how they look, opportunities in Asia’s aesthetic market will skyrocket.
Growth of the Asian cloud computing market is expected to accelerate as healthcare providers streamline their operations in today’s paperless world.
Cost savings and the ability to meet high-volume demands are enticing benefits.
In less than five years, the value of this market is expected to exceed $11 billion.
Recent healthcare and political changes are opening the door for medical device companies.